Published Thu, 09 Feb 2017 14:15:58 -0500 on Seeking Alpha
Pfizer Inc. (NYSE: PFE) is one of the world's largest pharmaceutical firms with sales exceeding $50 billion. The company is currently attractively valued at a blended P/E ratio of 13.3, offering a current dividend yield of 4%. Pfizer is awarded an S&P credit rating of AA and possesses a modest debt to capital ratio of 28%.
Prior to 2004, the company could have been described as a fast-growing dividend paying stock. However, since 2004, operating earnings growth has slowed considerably. Therefore, Pfizer was once a powerful total return producer that has morphed into a high-yielding blue-chip dividend paying stock offering only moderate growth potential and an above-average current yield.
Consequently, I believe that Pfizer is best suited for the prudent income-oriented investor seeking above-average current yield and safety. Therefore, Pfizer might be especially interesting to the retired investor looking for an above-average level of income in order to fund their retirement needs. However, I also intend to demonstrate that capital appreciation potential might also be surprisingly good going forward.
Pfizer It's All About The Dividend
I recently read an excellent article titled "Pfizer May Be Another IBM" that DoctoRx authored on Pfizer, and thought it was an excellent piece of research on the company. However, there were certain areas of the article that I did not agree with. To be clear, I found that the article contained... Read more
|Stock name||Last trade||P/E||Earnings/Share||Dividend/Share||Dividend yield|
Older articles featuring Pfizer (PFE):10 Dividend Growth Stocks For March 2018
S&P 500 'Safer' Dividend Gains Led By General Motors, Qualcom, & Invesco For March
'Safer' Dividend Big Gain Dow Dogs: McDonald's, Walmart, Procter, And United Per Broker March Metrics
Back Testing David Van Knapp's High Quality Dividend Growth Criteria
What Are The Highest Quality Dividend Growth Stocks?
Dividend Gainers: Sanofi, Lilly, Johnson & Johnson, & Gilead Are Tops Per Broker Targets To February 2019
Meet 21 Wall St. S&P Star 'Safer' Dividend Picks For February
IRA Portfolio 1 Year Buying-Selling Update And Now 5.8% Dividend Yield
Pfizer: 3.9% Dividend Well Above Industry Average
S&P 500 'Safer' Dividend Gains Led By Leggett, Simon & Ford For February